Literature DB >> 31424539

RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-Analysis.

Haiyan Yang1, Li Shi1, Ying Wang1, Guangcai Duan1, Yadong Wang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31424539      PMCID： PMC7156923          DOI： 10.1093/jnci/djz162

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

Authors:  C J van Asperen; R M Brohet; E J Meijers-Heijboer; N Hoogerbrugge; S Verhoef; H F A Vasen; M G E M Ausems; F H Menko; E B Gomez Garcia; J G M Klijn; F B L Hogervorst; J C van Houwelingen; L J van't Veer; M A Rookus; F E van Leeuwen
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

2.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

3.  Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

Authors:  H A Risch; J R McLaughlin; D E Cole; B Rosen; L Bradley; E Kwan; E Jack; D J Vesprini; G Kuperstein; J L Abrahamson; I Fan; B Wong; S A Narod
Journal:  Am J Hum Genet       Date:  2001-02-15       Impact factor: 11.025

4.  BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.

Authors:  Mok Oh; Ali McBride; Seongseok Yun; Sandipan Bhattacharjee; Marion Slack; Jennifer R Martin; Joanne Jeter; Ivo Abraham
Journal:  J Natl Cancer Inst       Date:  2018-11-01       Impact factor: 13.506

5.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

6.  The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.

Authors:  R Chen-Shtoyerman; A Figer; H H Fidder; P Rath; L Yeremin; S Bar Meir; E Friedman; L Theodor
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.